Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.
about
Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemiaFungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.Invasive candidiasis: update on current pharmacotherapy options and future perspectives.Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q31083746-4B956733-06A6-4819-BE44-0976F8C68429Q34418965-CF257E91-129F-49B1-B3A8-E89982EDBCE8Q35579273-D0335B52-1807-4601-9D09-F2120EAAB245Q36722703-B83F82C4-73E4-4F0D-AB62-68EE751D1622Q37280740-3C56BDEB-46CE-42E1-8716-C5D3A58D784BQ37528435-422E166E-9818-4721-802C-A489510AC330Q38053482-D43B9C4B-7E4C-4E02-AC55-09E37DE00238Q38110850-818E0A8B-2D81-4886-B29C-BC142D562C49Q38264086-68FC6AE8-F878-4E25-A7A1-7471E96F42F0Q38284455-413FF05B-22B5-4317-B778-988F3C2BE2DFQ40060170-1014A895-0B65-417B-B839-DD6A4CB6D01FQ40194039-457B11B5-D5E8-4EF9-AD30-91BBFEED196DQ41929675-A8CC6984-B2F0-439D-8F70-019D22C59DE0Q58775551-0B4B6357-FD1E-4DC7-BF27-7E1156B33687
P2860
Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antifungal chemoprophylaxis in ...... options for clinical practice.
@en
Antifungal chemoprophylaxis in ...... options for clinical practice.
@nl
type
label
Antifungal chemoprophylaxis in ...... options for clinical practice.
@en
Antifungal chemoprophylaxis in ...... options for clinical practice.
@nl
prefLabel
Antifungal chemoprophylaxis in ...... options for clinical practice.
@en
Antifungal chemoprophylaxis in ...... options for clinical practice.
@nl
P2093
P2860
P1433
P1476
Antifungal chemoprophylaxis in ...... options for clinical practice.
@en
P2093
Andreas H Groll
Athanasios Tragiannidis
Charalampos Dokos
Thomas Lehrnbecher
P2860
P304
P356
10.2165/11599810-000000000-00000
P577
2012-03-01T00:00:00Z
P6179
1008645634